Phase 1/2 study of KRN330, a fully human anti-A33 monoclonal antibody, plus irinotecan as second-line treatment for patients with metastatic colorectal cancer.
| Image |  |
|---|---|
| Description | scientific article published on 3 April 2014 |
| Author/s |
author: Thomas J George Heinz-Josef Lenz |
| Publication date | April 3, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |